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Oxidative and nitrosative stresses have been reported as detrimental phenomena concurring to the onset of several neurodegenera-
tive diseases. Here we reported that the ectopicmodulation of the denitrosylating enzyme S-nitrosoglutathione reductase (GSNOR)
differently impinges on the phenotype of two SH-SY5Y-based in vitro models of neurodegeneration, namely, Parkinson’s disease
(PD) and familial amyotrophic lateral sclerosis (fALS). In particular, we provide evidence that GSNOR-knocking down protects
SH-SY5Y against PD toxins, while, by contrast, its upregulation is required for G93A-SOD1 expressing cells resistance to NO-
releasing drugs. Although completely opposite, both conditions are characterized by Nrf2 localization in the nuclear compartment:
in the first case induced by GSNOR silencing, while in the second one underlying the antinitrosative response. Overall, our results
demonstrate that GSNOR expression has different effect on neuronal viability in dependence on the stimulus applied and suggest
that GSNOR could be a responsive gene downstream of Nrf2 activation.
1. Introduction
Oxidative and nitrosative stress has been copiously reported
to play a pivotal role in the onset of neurodegenerative
diseases [1, 2]. Both endogenous and exogenous sources of
nitrooxidative stress, such as mitochondria [3] and immune
cells [4] that produce reactive oxygen species (ROS) or
reactive nitrogen species (RNS) deriving from nitric oxide
(NO), deeply contribute to the persistence of noxious con-
ditions affecting neuron viability. Parkinson’s disease (PD)
and amyotrophic lateral sclerosis (ALS) are among the neu-
rodegenerative disorders in which nitrooxidative stress has
been particularly reported being implied in the loss of specific
neuronal populations.
PD is a neurodegenerative disorder that leads to a
progressive loss of dopaminergic neurons. The mechanisms
underlying this phenomenon are not completely clarified.
However, mitochondrial damages (mainly those affecting
complex I of the respiratory chain), failure in proteins, and
organelles quality control as well as oxidative and nitrosative
stress have been suggested to be implicated in the patho-
genesis of PD [5]. Several are the mutations associated with
the family forms of PD [6]. Many of them affect specific
proteins, for example, PINK1, Parkin, and DJ-1. In particular,
DJ-1 has been implicated in the protection against oxidative
insults as it interferes with the production of mitochondrial
ROS, and it has been reported to be undergoing activation
by S-nitrosylation processes [7–9]. Moreover, the existence
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of a signaling axis involving DJ-1 as upstream modulator of
Nrf2 (NE-F2-related factor-2) [10, 11], the transcription factor
known as one of the master regulators of redox homeostasis,
has recently been demonstrated, suggesting that DJ-1 may act
in different ways in order to counteract oxidative stress.
ALS is a multifactorial disease caused by motor neuron
degeneration that can be divided into a sporadic (90% of the
cases) and a familial form (fALS) whose 20% of mutations
(2% of total ALS cases) map throughout the SOD1 gene
(coding the Cu, Zn superoxide dismutase) [12, 13]. More
than 100 point mutations in SOD1 gene are associated with
fALS cases, with some of them affecting its antioxidant
activity. One of themost studied SOD1mutations is the G93A
substitution which results in the aggregation of the mutant
forms, being, in such a way, detrimental for mitochondrial
homeostasis and motor neuron survival. Another common
feature of ALS is the chronic inflammatory response activated
in the cells surrounding motor neurons (astrocytes and
microglia) that leads to the production of cytokines and NO
[14–16].
S-Nitrosylation represents one of the main NO-mediated
posttranslational modifications [7]. It is based on the attach-
ment of an NO moiety to the thiol group (-SH) of cys-
teine residues, resulting in the formation of low (amino
acids and peptides) and high molecular weight (pro-
teins) S-nitrosothiols (SNOs). Although NO could modulate
either neuronal viability or death, the role of neuronal
S-nitrosothiols (SNOs) in the etiopathogenesis of neuro-
degenerative diseases remains to be fully elucidated yet.
Protein aggregates found in brains from PD and ALS
patients show a great abundance of nitrated/S-nitrosylated
proteins, suggesting that SNOs are involved in the patho-
genesis and/or in the neuronal defense responses. However,
recent results [17] indicate that NO is a potent antioxidant
agent that reduces oxidative stress in the central nervous
system, such as by increasing the antioxidant capacity of
reduced glutathione (GSH) through the formation of S-nitro-
soglutathione (GSNO), which is a 100-fold more potent anti-
oxidant with respect to GSH.
It has been reported that class III alcohol dehydrogenase
[18] also known as S-nitrosoglutathione reductase (GSNOR)
catalyzes the degradation of GSNO, thus regulating the
amount of SNOs and NO bioactivity. Although GSNOR-
deficient (KO) mice are viable and fertile, they show some
pathological phenotypes, many of which related to aging,
such as (i) compromised lymphocytes development [19]; (ii)
highmorbidity andmortality upon endotoxic shock [20]; (iii)
DNA damage accumulation; (iv) high probability to develop
hepatocellular carcinoma [21, 22]; (v) early signs of periph-
eral neuropathy [23]. Altogether, this evidence indicates
that (i) excessive S-nitrosylation negatively impacts on cell
physiology and (ii) GSNOR acts as the principal molecular
modulator underneath. GSNOR, in fact, is the best character-
ized denitrosylating enzyme evolutionarily conserved from
bacteria to humans [24], which is widely expressed in all
tissues and organs. In particular, brain has been reported to
express high levels of GSNOR [24]. However, any alteration
linked to GSNOR deficiency in nervous system has never
been reported so far.
Based on the evidence that GSNOR deficiency results
in ageing-related phenotypes and that brain represents the
organ mostly affected during ageing, here we have aimed at
characterizing the role of GSNOR in modulating the severity
of two neurodegenerative diseases, PD and fALS, taking SH-
SY5Y as elective experimental system.
2. Materials and Methods
2.1. Cell Cultures. Human SH-SY5Y cells were purchased
from the European Collection of Cell Culture and grown
at 37∘C in an atmosphere of 5% CO
2
. SH-SY5Y cells were
cultured in DMEM-F12 containing 25mM glucose, supple-
mented with 10% fetal bovine serum, 2mML-glutamine, and
1,000U/mL penicillin-streptomycin. All media were from
Lonza. G93A-SOD1 stably expressing SH-SY5Y cells were
generated as previously reported [25]. LowNO clone was
selected from a mixed population of G93A cells subjected to
repeated treatments with GSNO.
2.2. Cell Transfection with siRNAs. 24 hours after plating, SH-
SY5Y cells were transfected with a commercially available
small interference RNA (siRNA) against GSNOR (Sigma).
Control cells were transfected with a scramble siRNA duplex
(siScr), which does not present homology with any other
humanmRNAs. In experiments aimed at downregulatingDJ-
1, double transfection (with both siRNAs against GSNOR and
DJ-1) was carried out simultaneously.
2.3. Treatments. All treatments were performed for 24 h in
completed culture media. DPTA was used at a concentration
of 400𝜇M, H
2
O
2
at 1mM, MPP+ at 1.25 or 2.5mM, and
6OHDA at 50𝜇M. Trigonelline was preincubated for 30min
before treatments with DPTA and used at a concentration of
0.5 or 1 𝜇M.
2.4. Analysis of Cell Death. Cell death was evaluated by
direct cell count at optic microscopy upon Trypan blue
staining or, cytofluorometrically, by assessing the percentages
of apoptotic cells upon staining with propidium iodide.
2.5. Animal Experimentation. All mouse experiments were
conducted in accordance with the European Community
guidelines and with the approval of relevant national (Min-
istry of Health) and local (Institutional Animal Care and
Use, Tor Vergata University) ethical committees. All mice
employed in the experiments (wild type, G93A, and GSNOR-
KO) were on C57BL/6J background. They have been raised
and crossed in the indoor animal house in a 12 h light/dark
cycle in a virus/antigen-free facility with controlled temper-
ature and humidity and have been provided with water and
food ad libitum. At the indicated time,micewere anesthetized
with ketamine–xylazine, killed, and dissected for the different
experiments. All efforts were made to minimize suffering.
2.5.1. Spinal Cords. Spinal cords were collected from wild
type (WT) and symptomatic (135-day-old) G93A-SOD1
mice B6.Cg-Tg(SOD1-G93A)1Gur/J (Jackson Laboratory, Bar
Harbor, ME, USA) minced and lysed by 40–60 strokes
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in Potter-Elvehjem homogenizer and supernatants used for
PSNOs detection and GSNOR activity.
2.5.2. Brains. Brains were collected from 2-month-old wild
type (WT) andGSNOR-deficient (KO)mice.Mesencephalon
(ventromedial zone) was then isolated, since it contains most
of the dopaminergic cells (which are affected in PD), minced
and lysed by 30–40 strokes in Potter-Elvehjem homogenizer
and supernatants used for Western blot analyses.
2.5.3. PCN. Mouse primary cortical neurons (PCN) were
obtained from cerebral cortices of E15 C57BL/6 mice (WT
and GSNOR-KO) embryos. Minced cortices were digested
with trypsin EDTA 0.25% at 37∘C for 7 minutes. Cells were
stained with 0.08% Trypan blue solution and only viable
cells were counted and plated at the density of 1 × 105/cm2
onto poly-d-lysine coated multiwell plates in 25mM glucose-
containing MEM medium supplemented with 10% fetal
bovine serum, 2mM glutamine, and 0.1mg/mL gentamicin.
After 1 hour, the medium was replaced with Neurobasal
medium containing antioxidant-free B27 supplement, 2mM
glutamine, and 0.1mg/mL gentamicin. Cell cultures were
kept at 37∘C in a humidified atmosphere containing 5% CO
2
.
Every 3 days, one-third of themediumwas replaced up to day
7, the time at which the cells were treated.
2.6. Western Blotting. Cell or tissue were lysed or homoge-
nized in a lysis buffer containing 50mM Tris-HCl (pH 8.0),
150mM NaCl, 1% NP-40, and 12mM Na-deoxycholate sup-
plemented with protease and phosphatase inhibitors cocktail.
Nuclei and cytosol were obtained as previously described
[26]. Protein concentration was determined by the Lowry
protein assay. Proteins were separated by SDS-PAGE and
transferred to nitrocellulose membranes that were probed
with the following antibodies: anti-nNOS (Santa Cruz), anti-
SOD1 (Santa Cruz), anti-LDH (Santa Cruz), anti-poly-ADP-
ribose polymerase 1 (PARP1), anti-actin (Santa Cruz), anti-
tubulin (Sigma), anti-GSNOR (Thermo Scientific), anti-DJ-1
(Santa Cruz), anti-AKT (Santa Cruz), anti-phospho-AKT
(Santa Cruz), anti-Nrf2 (Santa Cruz), and anti-H2B (Santa
Cruz). After immunostaining with appropriate secondary
horseradish peroxidase-conjugated goat anti-rabbit or anti-
mouse antibodies, bands were revealed using the Amersham
ECL detection system.
2.7. Detection of Oxidative Stress
2.7.1. ROS Evaluation. 30 minutes before the end of the
experimental time, cells were incubated with 50𝜇M H
2
-
DCF at 37∘C, washed, and resuspended in ice-cold PBS. The
fluorescence intensities of DCF, formed by the reaction of
H
2
-DCF with ROS, were analyzed cytofluorometrically by
recording FL-1 fluorescence.
2.7.2. Carbonylation. Carbonylated proteins were detected
using the Oxyblot Kit (Intergen, Purchase, NY) after reaction
with 2,4-dinitrophenylhydrazine (DNP) for 15 minutes at
25∘C. Sampleswere then resolved by 10%SDSpolyacrylamide
gel electrophoresis and DNP-derivatized proteins identified
by immunoblot using an anti-DNP antibody.
2.8. Evaluation of GSNOR Activity. GSNOR activity was
evaluated spectrophotometrically in clarified cell or spinal
cord lysates at 340 nm as previously described [20, 24].
2.9. Detection of S-Nitrosylated Proteins (PSNOs) and Pull-
Down. S-Nitrosylation assays were performed as previously
described [27]. In particular, cells or tissues were lysed or
homogenized in HEN buffer (25mM HEPES, 50mM NaCl,
0.1mM EDTA1% NP-40, protease inhibitors, pH 7.4). Free
cysteine residues were blocked with S-methyl methanethio-
sulfonate (MMTS). More specifically, 0.5–2mg of protein
samples were diluted to 1.8mL with HEN buffer (100mM
HEPES, 1mM EDTA, 0.1mM neocuproine, pH 8.0). Next,
0.2mL of 25% SDS is added along with 20𝜇L of 10% MMTS
(to reach a final volume of 2mL and final concentrations of
2.5% SDS and 0.1% MMTS) and incubated at 50∘C in the
dark for 15–20minwith frequent vortexes. Proteins were then
precipitated upon incubation with acetone, resuspended in
0.24mL HENS buffer (HEN buffer with 1% SDS), and trans-
ferred to a fresh tube containing biotin-HPDP (2.5mg/mL)
with or without sodium ascorbate (20mM). After incubation
with the HRP-conjugated streptavidin, biotinylated proteins
were revealed using the Amersham ECL detection system.
Ascorbate-free samples have been omitted for straightfor-
ward visualization and interpretation of data.
Once obtained, the pool of PSNOs was pulled down
by incubation with streptavidin and proteins there included
were revealed on SDS-PAGE upon incubation with specific
primary antibody (e.g., DJ-1).
2.10. Fluorescence Microscopy. Cells were cultured on cover-
slips, fixed with 4% paraformaldehyde, and permeabilized.
Polyclonal anti-Nrf2 andmonoclonal Grp75 (Millipore) were
used as primary antibodies and probed successively with
the appropriate Alexa Fluor 568-conjugated secondary anti-
body. To visualize nuclei and the actin cytoskeleton, cells
were incubated with the cell-permeable DNA-specific dye
Hoechst 33342 (Calbiochem-Novabiochem) and fluorescein
isothiocyanate- (FITC-) conjugated phalloidin (Invitrogen),
respectively. Images were digitized with a Cool Snap video
camera connected to a Nikon Eclipse TE200 fluorescence
microscope.
2.11. Fluorescence Microscopy Detection of Δ𝜓
𝑚
. JC-1 (Life
Technologies) was added to prewarmed cell medium at the
final concentration of 5𝜇g/mL in order to evaluateΔ𝜓
𝑚
. After
incubation for 10min at 37∘C, cells were washed in PBS and
analyzed using a EVOS Floid Cell Imaging Station.
2.12. Data Presentation. All experiments were done at least
three different times unless otherwise indicated. The results
are presented as means ± SD. Statistical evaluation was
conducted by ANOVA, followed by Bonferroni’s test. Com-
parisons were considered significant at 𝑃 < 0.05.
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Figure 1: Characterization of siGSNOR cells. (a) Western blotting of GSNOR in total cell lysates of SH-SY5Y cells transiently transfected for
18 h with siRNA against GSNOR (siGSNOR) or control scramble siRNA (siScr). (b) Analyses of GSNOR activity in siGSNOR and siScr cells.
Western blots shown are representative of at least 𝑛 = 3 independent experiments that gave similar results. Tubulin was selected as loading
control. Graphs shown represent the mean of data ± SD of 𝑛 = 3 independent experiments, ∗∗𝑃 < 0.01.
3. Results
3.1. GSNOR Downregulation Protects SH-SY5Y Cells from
MPP+-Induced Toxicity. In order to analyze the effects of S-
nitrosylation on the viability of dopaminergic cells challenged
with PD toxins, we selected the SH-SY5Y cell line inwhichwe
transiently knocked down GSNOR (siGSNOR cells) (Figures
1(a) and 1(b)). We then subjected the cells to different doses
of the mitochondrial toxin MPP+, used to recapitulate in
vitro PD-like conditions, and we analyzed cell viability by
Trypan blue staining. Dose response experiments indicted
that, except for the highest dose employed (namely, 10mM)
where viability was completely compromised, siGSNOR cells
were more resistant toMPP+-mediated toxicity (Figure 2(a)).
Cytofluorometric analyses upon propridium iodide staining
also demonstrated that the extent of Sub-G1 (apoptotic)
population was lower in siGSNOR cells (Figure 2(b)) upon
treatment with either 1.25 or 2.5 𝜇M MPP+. Coherently,
Western blot analyses of poly-ADP ribose polymerase 1
(PARP1) cleavage indicated that siGSNOR cells were almost
unaffected by treatment with 2.5mM MPP+ if compared
with the scrambled siRNA transfected controls (siScr) (Fig-
ure 2(c)). To confirm these results, we also treated the cells
with 50𝜇M 6-hydroxydopamine (6-OHDA), another toxin
usually employed to induce PD-like cell death. As expected,
results shown in Figure 2(d) confirmed that siGSNOR cells
were more resistant to PD toxin mediated challenge.
3.2. GSNOR Downregulation Correlates with a General
Decrease of Oxidative Stress. In order to figure out themolec-
ular events responsible for siGSNOR cell resistance to PD
toxins, we cytofluorometrically analyzed H
2
O
2
produced in
SH-SY5Y under basal conditions by means of incubations
with 2󸀠,7󸀠-dihydrodichlorofluorescein (DCF). Figure 3(a)
indicates that H
2
O
2
production was endogenously lower
in siGSNOR than siScr cells. Consistently, primary cortical
neurons (PCN) obtained from GSNOR-deficient (GSNOR-
KO) mice showed an endogenous production of H
2
O
2
significantly reduced with respect to the wild type (WT)
counterparts (Figure 3(b)). Dihydroethidine (DHE) staining
also showed that GSNOR-KO PCN exhibited low levels of
O
2
∙− (Figure 3(c)), confirming that GSNOR depletion was
associated with a general reduction of endogenous levels
of ROS. These lines of evidence were in agreement with
the observation that the extent of protein carbonylation
measured in lysates from mesencephalon of brains obtained
by GSNOR-KO mice was lower than the WT counterpart
(Figure 3(d)), suggesting that GSNOR deficiency could
induce an enhancement of the antioxidant defense.
3.3. GSNOR Downregulation Induces DJ-1 and Nrf2 Activa-
tion. In the search for the molecular determinants underly-
ing the decrease of oxidativemarkers observed uponGSNOR
downregulation or complete ablation, we focused on DJ-1,
whose increased expression and S-nitrosylation have been
reported playing a pivotal role in neuroprotection [9, 28, 29].
Results shown in Figure 4(a) indicate that DJ-1 was upregu-
lated in siGSNOR SH-SY5Y cells and that this correlated with
an increase in the phosphoactive form of AKT. Interestingly,
total brain lysates obtained fromWT andGSNOR-KOmouse
brains displayed the same trend (Figure 4(b)), which was
also associated with an increase of the S-nitrosylated form
of DJ-1 (Figure 4(c)), suggesting that DJ-1 was upregulated
and, reasonably, activated by S-nitrosylation upon GSNOR
downregulation. Coherently, transfectionwith siRNA against
DJ-1 resulted in a significant increase of MPP+-mediated
toxicity in siGSNOR cells, while it seemed to be completely
ineffective in siScr SH-SY5Y (Figure 4(d)).
We previously demonstrated that GSNOR-KO skeletal
muscle showed an induction of Nrf2 [23]. Moreover data
from the literature show that DJ-1 is an upstream modulator
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Figure 2: Cell death in siGSNOR cells. (a) Direct cell count upon Trypan blue staining of siScr and siGSNOR SH-SY5Y cells treated for 24 h
with 0.1 to 10mM MPP+. (b) Cytofluorimetric histogram of siScr and siGSNOR SH-SY5Y cells treated for 24 h with 1.25 or 2.5mM MPP+
upon propidium iodide staining percentage of subG1 (apoptotic) population is shown. (c) Western blotting of PARP1 in total cell lysates of
siScr and siGSNOR SH-SY5Y cells treated for 24 h with or without 2.5mM MPP+. Densitometric analyses reporting the ratio cleaved: full
length of PARP1 immunoreactive bands are shown on the top. (d) Direct cell count upon Trypan blue staining of siScr and siGSNOR SH-
SY5Y cells treated for 24 h with 50 𝜇M 6OHDA. Western blots shown are representative of at least 𝑛 = 3 independent experiments that gave
similar results. Tubulin was selected as loading control. Graphs shown represent the mean of data ± SD of 𝑛 = 3 independent experiments,
∗
𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001.
of the Nrf2-mediated antioxidant response [10, 11].Therefore,
we focused on this transcription factor. Namely, we analyzed
its nuclear versus cytosolic localization, which is commonly
accepted as predictive sign of Nrf2 activation. Immunoflu-
orescence analyses of PCN indicated that Nrf2 localization
significantly changed from being exclusively cytosolic and
axonal (WT) into predominantly nuclear (GSNOR-KO) (Fig-
ure 5(a)). Western blot analyses performed in cytosolic and
nuclear fractions of both siGSNOR SH-SY5Y and GSNOR-
KO brains indicated that nuclear levels of Nrf2 were higher if
compared with siScr and WT controls, respectively (Figures
5(b) and 5(c)), confirming previously obtained results and
reinforcing the hypothesis that Nrf2 was activated upon
GSNOR downregulation. In agreement with these observa-
tions, we inhibited Nrf2 with 1 𝜇M of its pharmacological
inhibitor trigonelline and analyzed cell death. Figure 5(d)
shows that preincubation with trigonelline significantly exac-
erbatedMPP+-induced toxicity in siGSNOR cells, arguing for
a role of Nrf2 in cell protection against MPP+ in conditions
of nitrosative stress.
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Figure 3: ROS production and protein carbonylation in GSNOR-downregulating systems. (a) Cytofluorimetric analyses of H
2
O
2
in siScr
and siGSNOR SH-SY5Y cells upon 2󸀠,7󸀠-dihydrodichlorofluorescein (DCF) staining. (b) Cytofluorimetric analyses of H
2
O
2
and O
2
∙− in
GSNOR-KO and WT PCN upon 2󸀠,7󸀠-dihydrodichlorofluorescein (DCF) or (c) dihydroethidine (DHE) staining. (d) Western blot analyses
of protein carbonyls frommesencephalon obtained fromGSNOR-KO andWT brains.Western blots shown are representative of at least 𝑛 = 3
independent experiments that gave similar results. Actin was selected as loading control. Graphs shown represent the mean of data ± SD of
𝑛 = 3 independent experiments, ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01.
3.4. GSNOR Decrease Sensitizes G93A-Expressing Models of
ALS to Nitrosative Stress. Next, we wondered to extend our
analyses and figure out any role of GSNOR in neurodegen-
erative disturbances where NO-mediated toxicity has been
frequently reported being a factor affecting neuronal viability.
In particular, we focused on ALS whose progression and
severity have been tightly correlatedwithNOoverproduction
and nitrosative stress. In order to verify whether excessive
S-nitrosylation occurred in ALS, we initially performed
biotin switch assays of S-nitrosylated proteins (PSNOs) in
spinal cord of mice overexpressing the fALS associated G93A
mutant form of SOD1 that we selected as in vivo elective
model of ALS; Figure 6(a) shows that PSNOs levels were
significantly increased in symptomatic G93A mice (135-day-
old), confirming the hypothesis thatALSwas accompanied by
aberrant S-nitrosylation. Interestingly, spectrophotometric
analyses indicated that this condition was associated with a
marked decrement of GSNOR activity (Figure 6(b)), suggest-
ing that GSNOR decrease could concur to nitrosative stress
and motor neuron death observed in ALS.
Coherently, we and others had already reported that
SOD1-G93A overexpression rendered SH-SY5Y cells (here-
after named G93A cells) sensitive to nitrosative stress [30],
and during our experiments we observed that 24 h treatments
with 400 𝜇M of the NO-donor DPTA induced higher extent
of apoptotic cells in G93A cells if compared with parental
SH-SY5Y cells (Figure 6(c)). Interestingly, this condition
was exacerbated by siRNA-induced GSNOR downregulation
(Figure 6(c)), adding in such a way a further evidence that
GSNOR could play a role in ALS, namely, in protecting ALS
motor neurons against nitrosative stress.
3.5. GSNOR Upregulation Induces Resistance to Nitrosative
Stress in G93A Cells. We then selected a clone of G93A cells
that significantly upregulated GSNOR and downregulated
nNOS (clone hereafter named as lowNO) (Figure 7(a)). This
clone still maintained the typical phenotype of fALS mutant
SOD1, such as mitochondrial fragmentation (Figure 7(b))
and depolarization (Figure 7(c)), together with an endoge-
nous production of ROS (Figure 7(d)). However, the extent
of protein carbonylation decreased in this clone (Figure 7(e)),
reinforcing the idea that NO directly contributes to carbony-
lation.
In agreement with high GSNOR levels, we found out
that the lowNO clone was highly resistant to 24 h treatment
with DPTA (Figure 7(f)), indicatingthat GSNOR induction
was protective against nitrosative challenge in in vitro fALS
models.
3.6. Nrf2 Contributes to Antinitrosative Response. In order
to characterize the GSNOR-based preconditioning response
underlying lowNO clone resistance to nitrosative stress,
we performed localization assays of Nrf2 by Western blot.
Figure 8(a) shows that Nrf2 preferentially distributed in the
nucleus of lowNO clone, arguing for Nrf2 being induced in
these cells. Consistently, incubation of lowNO clone with
trigonelline increased susceptibility to DPTA (Figure 8(b)),
allowing the hypothesis that Nrf2 activation and GSNOR
upregulation, both found in lowNO clone, were functionally
correlated inmediating resistance of G93A cells to nitrosative
stress.
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Figure 4: DJ-1 and AKT in siGSNOR cells and GSNOR-KO brains. Western blot analyses of DJ-1, as well as basal and phosphoactive AKT
in total extracts obtained from (a) siScr and siGSNOR SH-SY5Y cells or (b) GSNOR-KO andWT brains. Densitometric analyses of DJ-1 and
phospho-AKT are shown on the top of the corresponding Western blot normalized to actin and basal AKT, respectively. (c) Biotin switch
assay followed by pull-down with streptavidin and revealed with anti-DJ-1 antibody, in total extracts obtained from GSNOR-KO and WT
brains. Western blot analysis indicates that DJ-1 was S-nitrosylated (present in the pull-down). Western blots shown are representative of
at least 𝑛 = 3 independent experiments that gave similar results. Actin or GAPDH were selected as loading controls. (d) Direct cell count
upon Trypan blue staining of siScr and siGSNOR SH-SY5Y cells transfected or not with siRNA against DJ-1 (siDJ-1) and treated for 24 h with
2.5mMMPP+. Graphs shown represent the mean of data ± SD of 𝑛 = 3 independent experiments, ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01.
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Figure 5: Nuclear localization of Nrf2 in GSNOR-downregulating systems. (a) Fluorescence microscopy analyses of WT and GSNOR-KO
PCN upon staining with anti-Nrf2 antibody (red), phalloidin (green), and Hoechst 33342 (blue), with the last two probes used to selectively
highlight actin (cytoskeleton) and nuclei, respectively. Western blot analyses of Nrf2 in nuclear and cytosolic fractions obtained from (b)
siScr and siGSNOR SH-SY5Y cells or (c) GSNOR-KO and WT brains. Western blots shown are representative of at least 𝑛 = 3 independent
experiments that gave similar results. SOD1 and histone 2B (H2B) were selected as loading and purity controls of cytosol and nuclei,
respectively. (d) Direct cell count upon Trypan blue staining of siScr and siGSNOR SH-SY5Y cells treated for 24 h with 2.5mM MPP+ in
the presence or absence of 1mM of the Nrf2 pharmacological inhibitor trigonelline. Graphs shown represent the mean of data ± SD of 𝑛 = 3
independent experiments, ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01.
4. Discussion
In this work we have analyzed and characterized the role
of GSNOR and S-nitrosylation in modulating phenotype
severity of in vitro PD and fALS models. Despite the fact that
GSNOR is the only alcohol dehydrogenase highly expressed
in the central nervous system of mouse, rat, and humans
[24], to the best of our knowledge this is the first evidence
arguing for GSNOR being a crucial molecular player of
neuronal homeostasis. Interestingly, here we have provided
evidence that knocking down GSNOR expression results in
a significant protection against PD toxins, such as MPP+
and 6OHDA. We recently demonstrated that muscles from
GSNOR-KO mice show a clear fragmentation and depolar-
ization of the mitochondrial network, which are associated
with an endogenous activation of Nrf2-mediated antioxidant
response [23]. It is therefore plausible that, under these
conditions, mitochondria are less affected by MPP+ and
highly protected against any further production of ROS,
for example, that induced by 6OHDA. From this perspec-
tive, GSNOR downregulation represents a molecular event
responsible for neuronal cell adaptation against oxidative
stress and a possible tool to be exploited in order to counteract
PD onset and progression.
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Figure 6: Characterization and sensitivity of G93A models to nitrosative stress. Biotin switch assay of total protein-SNOs (a) and analysis
of GSNOR activity (b) performed on spinal cord lysates of WT and G93A-SOD1 expressing mice (G93A). (c) Cytofluorimetric analyses of
apoptosis upon propidium iodide staining performed on parental SH-SY5Y cells (WT) and G93A-SOD1 mutants (G93A) transfected or not
with siRNA against GSNOR (siGSNOR) and treated for 24 h with 400 𝜇M DPTA. Western blots shown are representative of at least 𝑛 = 3
independent experiments that gave similar results. Tubulin was selected as loading control. Graphs shown represent the mean of data ± SD
of 𝑛 = 3 independent experiments, ∗𝑃 < 0.05 and ∗∗∗𝑃 < 0.001; n.s.: not significant.
However, GSNOR downregulation should sensitize cells
to nitrosative stress. This is a crucial issue if we take into
account neurodegenerative diseases in which NO-mediated
toxicity highly contributes to the loss of specific neuronal
populations, such as motor neurons in ALS. In particular,
a direct role of chronic NO-based inflammatory response
activated by astrocytes and microglia has been reported in
ALS as detrimental event concurring to motor neuron cell
death [4]. In agreement, we observed that in vitro models
of fALS, namely, the SOD1-G93A SH-SY5Y cells, are highly
susceptible to the toxicity of the NO-releasing drug DPTA,
which is in line with previously published data obtained
with other NO donors [30]. In these conditions, ectopic
downregulation of GSNOR expression by siRNA exacerbates
NO-mediated cell death, confirming our hypothesis of a
protective role of GSNOR in cells susceptible to nitrosative
stress. Remarkably, in our studies we found out that G93A-
SOD1 expressing mice show an increase of spinal cord
PSNOs in association with a decrease of GSNOR activity.
This finding suggests for the first time that GSNOR is
downregulated in ALS and argues for GSNOR decrease being
a new marker of ALS onset and, mainly, progression. This
hypothesis is strengthened by the results obtained in the
GSNOR-overexpressing lowNO G93A clone which shows
resistance to DPTA, thereby indicating that S-nitrosylation
is a posttranslational modification strongly implicated in
driving motor neuron death response to nitrosative stress in
ALS.
Interestingly, our data support the hypothesis that Nrf2
could play a pivotal role also in these conditions. In par-
ticular, we have found out that cell adaptation induced by
lowNOG93A clone to survive to nitrosative stress conditions
(namely, GSNOR induction combined with nNOS downreg-
ulation) is associated, at least in part, with the induction
of Nrf2, as trigonelline significantly increases lowNO G93A
clone sensitivity to NO.
Altogether, these results argue for Nrf2 being tightly
related to GSNOR expression. In particular, while Nrf2 is
activated in response to (downstream of) GSNOR depletion
to protect against PD toxins-induced cell death, it could also
induce (be upstream of) GSNOR transcription to preserve
survival in in vitromodels of fALS in conditions of nitrosative
stress. A positive feedback loop between Nrf2 and GSNOR
could be therefore hypothesized to occur in order to sustain
cell viability in conditions of nitrooxidative stress. However,
if GSNOR is a direct target of Nrf2 still waits to be demon-
strated.
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